Categories: Entertainment

Sustainability Report 2024: ENNOVI Earns EcoVadis Platinum, CDP Recognition and Gold Asia Sustainability Award

SINGAPORE, Feb. 25, 2026 /PRNewswire/ — ENNOVI today announced the release of its Sustainability Report 2024, which highlights a year of strong external recognition for its sustainability performance, transparency and governance; reinforcing the company’s commitment to responsible operations, transparency and long-term value creation. ENNOVI achieved several milestones, including an EcoVadis Platinum rating for the fifth consecutive year, CDP Climate Change and Water Security scores of B, a CDP Supplier Engagement score of B-, and Gold recognition as Asia’s Best Sustainability Report (Private Company) at the 10th Asia Sustainability Reporting Awards.

- Advertisement -

“ENNOVI’s continued focus on operating responsibly, strengthening transparency and delivering measurable progress across our global operations is a cornerstone of ENNOVI culture,” said Stefan Rustler, CEO of ENNOVI. “From climate and energy management to safety, human rights and supplier standards, we are embedding sustainability into how we run our business and support our customers. While our sustainability report is an important marker of this work, it’s the dedication of our teams to this goal that we have achieved these honors.”

- Advertisement -

“This year’s report reflects a significant step forward in the depth and consistency of our sustainability disclosures,” said Nantha Kumar Chandran, Chief Sustainability Officer, ENNOVI. “With our fourth task force on climate-related financial disclosures (TCFD) report, inaugural human rights report, and third-party verified scope 1, 2 and 3 emissions data, we are strengthening the systems, data quality and governance needed to manage sustainability performance across our global operations.”

- Advertisement -

The report has been prepared with reference to internationally recognised frameworks and principles, including:

- Advertisement -
  • GRI Standards
  • SASB Standards
  • TCFD Recommendations
  • GHG Protocol
  • UN Global Compact (UNGC) Ten Principles
  • UN Sustainable Development Goals (SDGs)

Key performance highlights include the fact that 40% of its global workforce are women, a reflection of its ongoing commitment to diversity and inclusion, while 100% of key suppliers now have sustainability clauses embedded in their contracts, strengthening responsible sourcing across its value chain. The report also features case studies showcasing emissions-reduction initiatives across ENNOVI’s manufacturing operations, demonstrating practical actions through energy efficiency, renewable energy adoption and process optimisation.

- Advertisement -

The ENNOVI Sustainability Report 2024 is available for download at: https://ennovi.com/sustainability/

- Advertisement -

About ENNOVI
At ENNOVI, we design and manufacture products and solutions for electrical battery platform developments, power components, and signal interconnect design solutions. Using our decades of experience in electro-mechanical engineering and high-precision manufacturing, we work with OEMs and suppliers to bring their ideas to life. As an interconnect solutions partner, we accelerate the process for our customers by offering complete end-to-end manufacturing capabilities from R&D, design, and tooling to production. Learn more at www.ennovi.com.

- Advertisement -

Agency Contact:
Pretzl
Erin McMahon
erin.mcmahon@publitek.com 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/sustainability-report-2024-ennovi-earns-ecovadis-platinum-cdp-recognition-and-gold-asia-sustainability-award-302695090.html

- Advertisement -
PRNW Agency

Recent Posts

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

2 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

2 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

2 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

2 hours ago